American Journal of Clinical Oncology-Cancer Clinical Trials

Papers
(The H4-Index of American Journal of Clinical Oncology-Cancer Clinical Trials is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
The Impact of the COVID-19 Pandemic on Cancer Patients247
A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors128
Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody35
The Impact of COVID-19 on Patients With Cancer25
Treatment and Prevention of Brain Metastases in Small Cell Lung Cancer25
Impact of Pain, Opioids, and the Mu-opioid Receptor on Progression and Survival in Patients With Newly Diagnosed Stage IV Pancreatic Cancer23
Twitter23
Racial and Geographic Disparities in Endocrine Therapy Adherence Among Younger Breast Cancer Survivors21
Angiosarcoma of the Breast21
PARP Inhibitors in Newly Diagnosed and Recurrent Ovarian Cancer20
Impact of Use of Antibiotics on Response to Immune Checkpoint Inhibitors and Tumor Microenvironment19
Vaccination and Immune Checkpoint Inhibitors18
ACR–ASTRO Practice Parameter for the Performance of Stereotactic Body Radiation Therapy18
Early Palliative Care Is Associated With Reduced Emergency Department Utilization in Pancreatic Cancer17
Medical Cannabis in Cancer Patients17
Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel for Treatment of Metastatic Pancreatic Cancer16
0.025733947753906